[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Pages 3172-3173]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01142]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: National Vaccine Program Office, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services is hereby giving notice that a
meeting is scheduled to be held for the National Vaccine Advisory
Committee (NVAC). The meeting will be open to the public; public
comment sessions will be held during the meeting.
DATES: The meeting will be held on February 7 and 8, 2018. The meeting
times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become
available.
ADDRESSES: U.S. Department of Health and Human Services, Hubert H.
Humphrey Building, Great Hall, 200 Independence Avenue SW, Washington,
DC 20201. The meeting can also be accessed through a live webcast on
both days of the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/index.html.
Pre-registration is required for members of the public who wish to
attend the meeting and who wish to participate in the public comment
session. Individuals who wish to attend the meeting and/or participate
in the public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/index.html. Participants may also register by
emailing [email protected] or by calling (202) 690-5566 and providing their
name, organization and email address.
FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S.
Department of Health and Human Services, Room 715H, Hubert H. Humphrey
Building, 200 Independence Avenue SW, Washington, DC 20201. Phone:
(202) 690-5566; email: [email protected].
[[Page 3173]]
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and
Human Services was mandated to establish the National Vaccine Program
to achieve optimal prevention of human infectious diseases through
immunization and to achieve optimal prevention against adverse
reactions to vaccines. The NVAC was established to provide advice and
make recommendations to the Director of the National Vaccine Program on
matters related to the Program's responsibilities. The Assistant
Secretary for Health serves as Director of the National Vaccine
Program. During the February 2018 NVAC meeting, sessions will consist
of presentations on vaccine innovation, including the current status of
adjuvants in vaccines, universal influenza, and an overview on the
Secretary of the Department of Health and Human Services' Report to
Congress on Vaccine Innovation in response to the 21st Century Cures
Act; a report out on the recently approved Presidential Advisory
Council on Combatting Antibiotic-Resistant Bacteria Report,
``Incentivizing the Development of Vaccines, Therapeutics, and
Diagnostics to Combat Antibiotic Resistant Bacteria''; disparities in
adult immunizations; and an update on strategies to support improving
coverage for human papillomavirus vaccine. Please note that agenda
items will be related to the charge of the Committee and are subject to
change as priorities dictate. Information on the final meeting agenda
will be posted prior to the meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
Public attendance at the meeting is limited to the available space.
Individuals who plan to attend in person and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the National Vaccine Program Office at
the address/phone number listed above at least one week prior to the
meeting. For those unable to attend in person, a live webcast will be
available. More information on registration and accessing the webcast
can be found at http://www.hhs.gov/nvpo/nvac/meetings/index.html.
Members of the public will have the opportunity to provide comments
at the NVAC meeting during the public comment periods designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Individuals are also welcome to submit their written
comments. Written comments should not exceed three pages in length.
Individuals submitting written comments should email their comments to
the National Vaccine Program Office ([email protected]) at least five
business days prior to the meeting.
Dated: January 17, 2018.
Roula Sweis,
Deputy Director, National Vaccine Program Office.
[FR Doc. 2018-01142 Filed 1-22-18; 8:45 am]
BILLING CODE 4150-44-P